{'fraction_non_alphanumeric': 0.02373887240356083, 'fraction_numerical': 0.005934718100890208, 'mean_word_length': 5.367924528301887, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Evaluation of a novel non‐invasive 13C‐glucose breath test for the identification of diabetes mellitus in cirrhotic patients

Aim:  Diabetes mellitus (DM) has been reported to worsen the long‐term prognosis of cirrhotic patients, and many studies have reported that DM is an independent risk factor for hepatocellular carcinoma. However, an accurate diagnosis of DM is sometimes difficult in cirrhotic patients. Recently, a novel non‐invasive 13C‐glucose breath test has been reported to be useful for diagnosing insulin resistance in non‐cirrhotic patients. The aim of this study was to evaluate the efficacy of this tool for the identification of DM in cirrhotic patients.